The organizations in the consortium will identify, characterize, and catalog human biological molecules affected by physical activity in volunteer biosamples.
Vanderbilt University, the University of Colorado at Denver, Partners HealthCare, and the Montreal Heart Institute will use Illumina technology to analyze their biobank samples.
The new findings point towards creating different treatment strategies for combating the disease in old and young patient groups.
The partners will evaluate whether circulating tumor DNA profiling has use for monitoring treatment response and relapse in melanoma patients.
Kauffman Foundation, MIT, BioAMPS, University of Colorado, Endo Pharma, Harvard, Galapagos, Flanders Institute of Biotechnology, and more …
Funding from the National Institutes of Health for all proteomics-related research shrank by almost 3 percent in fiscal 2008, according to an analysis of NIH data by ProteoMonitor.
A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.
Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.
Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.
In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.